Seanergy Dermatology
Therapeutics for Atopic Dermatitis, Psoriasis, and Other Inflammatory Conditions
Startup Seed Health Tech & Life Sciences Est. 2018
Total Raised
Undisclosed
Seed
Last Round
Undisclosed
1 rounds
Investors
1
1 public
Team
3
1-10 employees
Confidence
87/100
Patents
1
About
Seanergy is a clinical stage pharmaceutical company developing a new category of topical therapeutics for treatment of inflammatory and other skin conditions. Its patented technology is based on the discovery of a synergistic mechanism between anti-inflammatory APIs and Sulphated Polysaccharides extracted from algae.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
BiologicalsMicroorganisms
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business Model
B2B
Tags
pharmaceuticalsalgaeanti-inflammatoryinflammatory-diseasestopical-treatmenttherapeuticsdermatology
Funding & Events
Feb 2020
Undisclosed Round Undisclosed
Maruho Israel Innovation Fund
Details
Product Stage
Clinical Trial
Employees
1-10
Exact Count
6
District
Center District
Founded
2018
Registrar
515812089
Locations
Yitzhak Modai St 2, Rehovot, Israel
Links
Admin
Last Update
Aug 27, 2025
Verified by
Yotam Maman
Missing
video or image, news, markets, external profiles, not claimed
Team (3)
Eran Perry
Co-founder
Founder
Masanobu Ogawa
Co-founder
Founder
Doron Friedman
Co-founder
Founder
Internal
Created by
Yotam Maman (yotamm1988@gmail.com)
Created
2020-12-22T00:00:00.000Z
Last editor
Yotam Maman (yotamm1988@gmail.com)